A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab.

Future Oncol

Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.

Published: October 2023

Download full-text PDF	Source
http://dx.doi.org/10.2217/fon-2023-0284	DOI Listing

Publication Analysis

plain language

language summary

summary group

group patients

patients chrysalis

chrysalis study

study egfr

egfr exon

exon insertion-mutated

insertion-mutated non-small-cell

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!